Drug Research
Science organisations collaborate to create North East bioscience hub
CPI, FUJIFILM Diosynth Biotechnologies and Teesside University announced a collaboration to accelerate the bioscience sector in the Tees Valley Region. Named the Northern Bio-Accelerator Partnership (NBioP), the new collaboration will create a bioprocessing, biomanufacturing and biopharmaceutical hub in the...
Drug Research
Thermo Fisher Scientific Expands Clinical Supply Chain Services in Europe
To meet accelerating demand for robust clinical supply chain services throughout Europe, Thermo Fisher Scientific has expanded its pharma services footprint with two new state-of-the-art facilities in Rheinfelden and Weil am Rhein, Germany. The new sites will bring much-needed...
Drug Research
Fusion Antibodies and Queens University Belfast Receive Invest Northern Ireland Grant to Boost Research and Development for COVID-19 Antibodies
Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts. Within...
Drug Research
U.S. FDA confirms Pfizer COVID vaccine safe & effective
The FDA 53-page briefing document gives a green signal to Pfizer-BioNTech COVID-19 vaccine. A US roll-out of the vaccine is expected post-approval from an outside panel of scientific advisers who will review the FDA report on Thursday.
As COVID cases...
Drug Research
UK Begins The Biggest Immunization Program In Its History
The UK has begun immunizing citizens against Coronavirus.
Population above 80, the most vulnerable and the front line health care workers to be administered with the Pfizer COVID-19 vaccine in the first phase.
There is a history in the...
Drug Research
Russia Begins Sputnik V Coronavirus Vaccine Distribution
Sputnik V has been rolled out in Moscow and will be subsequently distributed across other Russian cities.
One needs to see if this will halt the growing number of COVID-19 cases in the country.
Sputnik V to be...
Drug Research
KaliVir Immunotherapeutics, Astellas ink research agreement to develop and commercialise VET2-L2 novel oncolytic virus
KaliVir Immunotherapeutics LLC and Astellas Pharma Inc announced that they entered into a worldwide licensing agreement for the research, development, and commercialization of VET2-L2, an intravenously administered oncolytic virus for Immuno-Oncology, as well as a research collaboration to generate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
